Skip to content
Dx

ICD-10-CM 2027 diagnosis code

E70.331Hermansky-Pudlak syndrome

✓ Billable / specificCC — complication/comorbidity

E70.331 is a valid, billable ICD-10-CM code for hermansky-pudlak syndrome. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Looking up by condition? See ICD-10 code for Hermansky-Pudlak syndrome.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About E70.331

E70.331 is the ICD-10-CM diagnosis code for Hermansky-Pudlak syndrome. It belongs to category E70 (disorders of aromatic amino-acid metabolism), block E70-E88 (metabolic disorders) and chapter 4 (endocrine, nutritional and metabolic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within E70.33 (albinism with hematologic abnormality), E70.331 is specifically for Hermansky-Pudlak syndrome. Related codes cover Chediak-Higashi syndrome (E70.330), other albinism with hematologic abnormality (E70.338) and unspecified (E70.339).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 642 (Inborn and Other Disorders of Metabolism, relative weight 1.3219), in MDC 10 (Endocrine, Nutritional and Metabolic Diseases and Disorders), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 270.2 (other disturbances of aromatic amino-acid metabolism).

Notes that apply from higher levels

Instructions written at a parent level also apply to E70.331.

Alphabetic index entries

2 entries

Terms in the official ICD-10-CM index that lead to E70.331.

Codes whose notes reference E70.331

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

MDC 10 · Endocrine, Nutritional and Metabolic Diseases and Disorders

ICD-9-CM equivalent

Converter →
  • 270.2Other disturbances of aromatic amino-acid metabolismapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about E70.331

Is E70.331 billable?

Yes. E70.331 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can E70.331 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict E70.331 as a principal diagnosis.

Is E70.331 a CC or MCC?

E70.331 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does E70.331 group to?

E70.331 is used in the MS-DRG v44.0 logic for MS-DRG 642 (Inborn and Other Disorders of Metabolism). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for E70.331?

The CMS General Equivalence Mappings map E70.331 to ICD-9-CM 270.2.